Remus Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0O5T01011
  • NSEID: REMUS
  • BSEID:
INR
737.85
19.1 (2.66%)
BSENSE

Jul 21, 03:30 PM

BSE+NSE Vol: 1100

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRemus Pharma. VS Pharmaceuticals & Biotechnology
 
1D
2.66%
-0.21%
1W
2.78%
0.56%
1M
-7.76%
0.73%
YTD
5.08%
-7.43%
1Y
-22.25%
-3.6%
3Y
84.37%
22.5%
5Y
%
54.73%
10Y
%
184.22%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.14%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.48%
0%
15.48%
6 Months
12.65%
0%
12.65%
1 Year
-22.25%
0.11%
-22.14%
2 Years
-23.08%
0.14%
-22.94%
3 Years
84.37%
0.77%
85.14%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.5 per share ex-dividend date: Nov-14-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Remus Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-5.31%
4
Quartile
quartile-4
Mar-Jun
24.1%
1
Quartile
quartile-1
Dec-Mar
-10.58%
3
Quartile
quartile-3
YTD
-22.25%
4
Quartile
quartile-4
2025
-43.77%
1
Quartile
quartile-1
2024
30.53%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Remus Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-5.31%
3
Quartile
quartile-3
Mar-Jun
24.1%
2
Quartile
quartile-2
Dec-Mar
-10.58%
3
Quartile
quartile-3
YTD
-22.25%
4
Quartile
quartile-4
2025
-43.77%
2
Quartile
quartile-2
2024
30.53%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Remus Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-5.31%
3
Quartile
quartile-3
Mar-Jun
24.1%
1
Quartile
quartile-1
Dec-Mar
-10.58%
3
Quartile
quartile-3
YTD
-22.25%
4
Quartile
quartile-4
2025
-43.77%
2
Quartile
quartile-2
2024
30.53%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available